JPMORGAN CHASE & CO

Holdings History for TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (TXMD)

Symbol: TXMD on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	0%	$477	293	0		$1.63	Q4 2025
30 Sep 2025	0%	0%	$310	293	0		$1.06	Q3 2025
30 Jun 2025	0%	0%	$339	293	-20	-6.4%	$1.16	Q2 2025
31 Mar 2025	0%	0%	$290	313	-2		$0.93	Q1 2025
31 Dec 2024	0%	0%	$271	315	+22	+7.5%	$0.86	Q4 2024
30 Sep 2024	0%	0%	$486	293	0		$1.66	Q3 2024
30 Jun 2024	0%	0%	$471	293	0		$1.61	Q2 2024
31 Mar 2024	0%	0%	$671	293	0		$2.29	Q1 2024
31 Dec 2023	0%	0%	$659	293	-20	-6.4%	$2.25	Q4 2023
30 Sep 2023	0%	0%	$945	313	0		$3.02	Q3 2023
30 Jun 2023	0%	0%	$1,289	313	+3	+0.97%	$4.12	Q2 2023
31 Mar 2023	0%	0%	$1,188	310	+147	+90%	$3.83	Q1 2023
31 Dec 2022		0%	$1,000	260	0		$3.85 ^*	Q4 2022
31 Dec 2022	0%	0%	$1,000	163	-97	-37%	$6.13	Q4 2022
30 Sep 2022	0%	0%	$2,000	260	-23	-8.1%	$7.69	Q3 2022
30 Jun 2022	0%	0%	$3,000	283	+283	NEW	$10.60	Q2 2022
30 Jun 2022		0%	$1,000	53	0		$18.87 ^*	Q2 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.